Skip to main
BTSG

BTSG Stock Forecast & Price Target

BTSG Analyst Ratings

Based on 13 analyst ratings
Buy
Strong Buy 46%
Buy 54%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

BrightSpring Health is expected to continue their success due to their strong market position, partnerships with drug manufacturers for outcomes-based contracts, and a goal of doubling their business size through acquisitions. However, potential risks include delays in FDA approvals and strained relationships with manufacturers. With a target price of $81, this company is recommended as a Buy due to its strong financial performance and focus on profitable growth.

Bears say

BrightSpring Health is facing challenges in integration and potential regulatory changes, along with competition in the healthcare industry, despite their recent positive financial performance. While they have strategic initiatives in place and partnerships with independent pharmacies, their reliance on the Pharmacy Solutions segment puts them at risk for fluctuations in revenue. Additionally, divesting their community living business may not be enough to improve margins, and the success of their home-based primary care focus remains uncertain.

BTSG has been analyzed by 13 analysts, with a consensus rating of Buy. 46% of analysts recommend a Strong Buy, 54% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of BrightSpring Health Services Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About BrightSpring Health Services Inc (BTSG) Forecast

Analysts have given BTSG a Buy based on their latest research and market trends.

According to 13 analysts, BTSG has a Buy consensus rating as of Aug 25, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $76, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $76, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

BrightSpring Health Services Inc (BTSG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.